Gold Bond Asbestos Exposure: National Gypsum Products, Trust Claims & Compensation

Gold Bond is a longstanding National Gypsum building-products brand. Historical court records and National Gypsum’s own interrogatory information document asbestos-containing Gold Bond joint treatment materials used in construction. The product evidence is specific: the Gold Bond line included both asbestos-containing and non-asbestos products, so a brand name alone does not establish asbestos content.

Old National Gypsum filed Chapter 11 on October 28, 1990. The 1993 reorganization transferred the operating Gold Bond business to a new National Gypsum company while legacy asbestos liabilities remained with the old company, renamed Asbestos Claims Management Corporation. Those liabilities are now administered through the NGC Bodily Injury Trust. The Trust’s official FAQ currently states a 40% Payment Percentage. It lists a $22,500 Expedited Review Allowed Liquidated Value for mesothelioma, producing a $9,000 mathematical illustration at the current 40% rate, subject to claim approval and Trust procedures.

🏢 Gold Bond & National Gypsum History

National Gypsum was incorporated in 1925. Gold Bond became one of its principal building-product identities. The current National Gypsum organization continues to market modern products under Gold Bond, ProForm and PermaBASE brands; historical asbestos evidence should not be used to imply that current Gold Bond products contain asbestos.

Company & Trust History

Topic	Confirmed information
Historical company	Old National Gypsum Company.
Founded	1925.
Historical brand	Gold Bond.
Chapter 11 filing	October 28, 1990, Northern District of Texas.
1993 confirmation	March 9, 1993.
Operating business after reorganization	New National Gypsum acquired operating assets/business of Gold Bond Building Products division.
Legacy asbestos entity	Old NGC became Asbestos Claims Management Corporation (ACMC).
Current claims mechanism	NGC Bodily Injury Trust.
Current modern brand	Gold Bond remains a current National Gypsum-affiliated building-products brand.

Reorganization Timeline

Date / period	Development
1925	National Gypsum incorporated.
Mid-20th century	Gold Bond building products included asbestos-containing and non-asbestos products.
October 28, 1990	Old NGC and parent filed Chapter 11.
March 9, 1993	Bankruptcy court confirmed reorganization plan.
1993	New NGC acquired operating Gold Bond division; Old NGC became ACMC.
1993 plan	NGC Settlement Trust established to resolve/fund legacy asbestos liabilities.
Later restructuring	NGC Bodily Injury Trust became the mechanism for remaining bodily-injury asbestos claims.
2026	Official NGCBIT website remains active and publishes current claim procedures.

See Construction Materials Companies & Asbestos Exposure.

🧱 Gold Bond Asbestos Products

Published federal and state decisions confirm asbestos-containing Gold Bond joint treatment products. National Gypsum interrogatory information quoted in litigation describes asbestos fibers used in Gold Bond joint treatment materials and identifies packaging and warning-label practices. Importantly, the Gold Bond line also included products without asbestos.

Documented Historical Products

Product / category	Evidence-based treatment
Gold Bond Joint Compound	Court records identify asbestos-containing historical formulations.
Gold Bond Joint Cement	Eleventh Circuit record states National Gypsum conceded the identified historical joint cement contained asbestos.
Gold Bond joint treatment materials	National Gypsum historical interrogatory information documents asbestos use.
Dry joint treatment materials	National Gypsum began asbestos caution labels in mid-1972 according to historical interrogatory information.
Ready-mixed joint treatment	Caution labels added in late 1973 or early 1974 according to historical records.
Other Gold Bond products	Brand included asbestos-containing and non-asbestos products; product-specific proof matters.

Historical Asbestos / Label Evidence

Issue	Documented information
Asbestos purpose	Historical National Gypsum response says asbestos was used in Gold Bond joint treatment materials for workability, strength and durability.
Earlier fiber sources	Historical response identifies grade 7RF and 7T asbestos purchased primarily from several asbestos suppliers.
Around 1967	National Gypsum began using Union Carbide SG-210 fiber in joint treatment materials.
Dry-product warning	Asbestos ‘Caution’ label began in mid-1972.
Ready-mix warning	Asbestos caution label began late 1973 or early 1974.
Packaging	Historical joint treatment materials were packaged in bags, boxes, cans and pails.

👷 Workers, Trades & Jobsites

Gold Bond joint treatment materials were used in wallboard finishing. Published cases document drywall and construction workers applying and sanding Gold Bond compound, activities that could create substantial dust when historical asbestos-containing formulations were involved.

Workers & Trades to Investigate

Worker / trade	Potential historical activity
Drywall finishers / tapers	Mixing, applying and sanding joint compound.
Drywall installers	Working near compound application and sanding.
Painters	Preparing and sanding finished wall surfaces.
Carpenters	Working around wallboard finishing.
Construction laborers	Cleanup of joint-compound dust and debris.
Plasterers	Handling related wall-finishing materials.
Maintenance workers	Repairing historical walls and ceilings.
Remodelers / demolition workers	Disturbing old wall-finishing materials.

Potential Jobsites

Setting	Evidence to investigate
Residential construction	Product bags/boxes, contractor records and coworker testimony.
Commercial construction	Specifications, invoices and drywall-contractor records.
Schools / hospitals	Renovation and maintenance records.
Industrial facilities	Construction and maintenance files.
Building-supply operations	Sales, purchasing and inventory records.
Renovation sites	Original construction dates and product identification.

Need help now? Call 800.291.0963
Live chat is available 24/7, 365 days a year.
Submit Your Case

🌫️ How Gold Bond Exposure Occurred

Historical drywall work could generate dust when dry compound was mixed, applied material was sanded, or residue was swept and cleaned. A Pennsylvania appellate decision describes a worker breathing dust from Gold Bond joint compound and cites National Gypsum interrogatories identifying Union Carbide as the exclusive asbestos supplier for Gold Bond joint compound from approximately 1967 through 1975.

Potential Exposure Activities

Activity	Potential pathway
Opening / mixing dry compound	Dust from historical asbestos-containing powder.
Applying joint treatment	Direct handling of qualifying material.
Sanding dried compound	Airborne finishing dust.
Sweeping / cleanup	Re-suspension of settled dust.
Wall repair	Disturbance of historical joint treatment.
Renovation / demolition	Breaking or removing finished wall systems.

Exposure Questions

Question	Why it matters
Was the product actually Gold Bond/National Gypsum?	Trust requires exposure to NGC asbestos product(s).
Which Gold Bond product was involved?	The brand included asbestos and non-asbestos products.
When was it used?	Formulation and supplier history changed over time.
What work generated dust?	Supports exposure pathway.
How often and how close was exposure?	Relevant to medical/exposure analysis.
Can records or witnesses corroborate use?	Strengthens Trust evidence.

⚖️ NGC Bodily Injury Trust & Claims

The NGC Bodily Injury Trust administers qualifying asbestos bodily-injury claims arising from products manufactured, sold or distributed by old National Gypsum/ACMC. The Trust’s official FAQ currently states a 40% Payment Percentage and says the percentage applies to all disease Allowed Liquidated Values (ALVs).

Current Trust Facts

Trust fact	Confirmed information
Trust	NGC Bodily Injury Trust.
Purpose	Liquidate and pay qualifying asbestos claims under Trust claims procedures.
Claims processor / service	Trust claims are administered through the Trust’s current claims system.
Review types	Expedited Review (ER) and Individualized Review (IR).
Current Payment Percentage	40% according to official Trust FAQ reviewed in September 2026.
Payment method	Allowed amount × then-current Payment Percentage after required release/indemnity.
Processing	FIFO processing for ER and IR claims.
Payment schedule	Official FAQ says payments are scheduled monthly, subject to volume.
Compensation guarantee	None.

Official Allowed Liquidated Values

Disease	ER ALV	IR Baseline ALV	Extraordinary Maximum
Mesothelioma	$22,500	$45,000	$180,000
Lung Cancer	$3,750	$7,500	$30,000
Other Cancer	$1,600	$3,200	$12,800
Non-Malignant I	$1,000	$2,000	$8,000
Non-Malignant II	$500	$1,000	$4,000
Non-Malignant III	$250	N/A	N/A

40% Expedited-Review Examples

ER Allowed Liquidated Value	Mathematical illustration at 40%
$22,500 Mesothelioma	$9,000.
$3,750 Lung Cancer	$1,500.
$1,600 Other Cancer	$640.
$1,000 Non-Malignant I	$400.
$500 Non-Malignant II	$200.
$250 Non-Malignant III	$100.

These are mathematical illustrations, not guaranteed payments. A claim must satisfy the Trust’s medical and exposure criteria. The Payment Percentage may change, and Individualized Review or Extraordinary Claim values are determined under separate Trust procedures.

📊 Documented Gold Bond Asbestos Cases

Published decisions provide direct evidence of historical asbestos-containing Gold Bond joint treatment materials and also illustrate why product identification matters. The Gold Bond brand covered multiple products, not all of which contained asbestos.

Selected Court Records

Record	Significance
Lee v. National Gypsum, 11th Cir. (1985)	Documents Gold Bond product line containing asbestos and non-asbestos products; National Gypsum conceded historical Gold Bond Joint Cement at issue contained asbestos.
Petrina v. Allied Glove, Pa. Super. Ct. (2012)	Describes testimony of dust exposure from Gold Bond joint compound and National Gypsum interrogatory evidence on asbestos supplier history.
Leathers asbestos litigation, Del. Super. Ct. (2017)	Worker hung sheetrock, applied joint compound and sanded walls while using National Gypsum Gold Bond joint compound.
Garner v. NGC Bodily Injury Trust, W.D.N.Y. (2012)	Federal litigation recognizes the Trust as the bankruptcy-established entity assuming National Gypsum asbestos bodily-injury liability.
NGC Trust official history	Confirms Old NGC bankruptcy, 1993 plan, New NGC Gold Bond asset acquisition and ACMC legacy-liability structure.
Current National Gypsum website	Confirms Gold Bond remains a modern affiliated product brand; historical asbestos content should not be attributed to current products.

Evidence Limits

Finding	Correct interpretation
Historical Gold Bond joint treatment materials contained asbestos	Confirmed.
Every Gold Bond product contained asbestos	No.
Current Gold Bond products contain asbestos	Not inferred from historical records.
Any Gold Bond exposure automatically qualifies for Trust payment	No.
$22,500 mesothelioma ER ALV equals current cash payment	No; current Trust percentage is 40%.
Trust compensation is guaranteed	No.

📋 Claim Evidence & Trust Requirements

The official Trust FAQ says documentation supporting both the claimed asbestos-related disease and exposure to NGC asbestos product(s) must be submitted. A verified work history and product/exposure evidence can therefore be central to a Gold Bond claim.

Evidence That May Help

Medical and pathology documentation supporting the claimed disease.
Employment, union and Social Security records.
Gold Bond bags, boxes, cans, pails, labels, invoices or photographs.
Drywall contractor, construction and building records.
Coworker testimony identifying Gold Bond joint treatment products.
Evidence describing mixing, application, sanding or cleanup.
Verified work history as required by Trust procedures.
Current NGC Bodily Injury Trust claim form and filing instructions.

Claim Checklist

Step	Question
1	Is the asbestos-related disease medically documented?
2	Can an Old NGC asbestos-containing product be identified?
3	Was the product Gold Bond joint compound, joint cement or another qualifying product?
4	Where and when did exposure occur?
5	Is the work history adequately verified?
6	Is ER or IR review appropriate?
7	Has the current 40% Payment Percentage been verified on the official Trust website?
8	Are applicable filing deadlines/tolling rules satisfied?

Current Trust Filing Points

Issue	Official Trust information
Medical evidence	Required to support claimed asbestos-related disease.
Exposure evidence	Required to support exposure to NGC asbestos product(s).
FIFO	ER and IR claims processed in received order.
Incomplete submission	Trust FAQ describes a deficiency process and cure period.
Malignant claims	Deadline rules depend on diagnosis/death dates and applicable tolling.
Pro se claims	Official FAQ says unrepresented claimants use paper filing and may choose ER or IR.

Compensation is not guaranteed. The Trust’s Payment Percentage can change, and eligibility depends on current Claims Resolution Procedures.

❓ Frequently Asked Questions

Did Gold Bond products contain asbestos?

Some historical Gold Bond products did. Published court records and National Gypsum interrogatory information document asbestos-containing Gold Bond joint treatment materials. The Gold Bond line also included products without asbestos.

Who manufactured Gold Bond asbestos products?

Historical Gold Bond building products were associated with Old National Gypsum Company. After the 1993 reorganization, the operating Gold Bond business transferred to New National Gypsum while legacy asbestos liabilities remained with ACMC/Trust structures.

Does Gold Bond have an asbestos trust?

Qualifying legacy National Gypsum/Gold Bond asbestos claims are administered through the NGC Bodily Injury Trust.

What is the current NGC Bodily Injury Trust Payment Percentage?

The official Trust FAQ currently states that the Payment Percentage is 40% and applies to all disease Allowed Liquidated Values.

What is the mesothelioma Expedited Review value?

The official Trust lists a $22,500 Expedited Review Allowed Liquidated Value for mesothelioma. At the current 40% Payment Percentage, the mathematical illustration is $9,000, subject to approval and Trust procedures.

What Gold Bond work could create asbestos dust?

Historical mixing of dry joint compound, application, sanding, sweeping and cleanup could generate dust when an asbestos-containing formulation was involved.

Do current Gold Bond products contain asbestos?

This page does not make that claim. Current Gold Bond products are modern products of affiliated National Gypsum entities; historical asbestos evidence should not be generalized to current formulations.

What evidence may support an NGC Trust claim?

The Trust requires documentation supporting the asbestos-related disease and exposure to NGC asbestos product(s). Work history, product records, invoices, photographs and coworker testimony may help.

🧾 Gold Bond Asbestos Summary

Detail	Confirmed / carefully qualified information
Historical manufacturer	Old National Gypsum Company.
Brand	Gold Bond.
Primary documented asbestos category	Historical joint treatment materials including joint compound/joint cement.
Old NGC Chapter 11	October 28, 1990.
1993 plan confirmation	March 9, 1993.
Legacy asbestos entity	Asbestos Claims Management Corporation (ACMC).
Trust	NGC Bodily Injury Trust.
Current Payment Percentage	40%.
Mesothelioma ER ALV	$22,500.
Mesothelioma ER 40% illustration	$9,000, not guaranteed.
Lung Cancer ER ALV	$3,750.
Other Cancer ER ALV	$1,600.
Guaranteed compensation	No.

📚 Confirmed Primary & Court Sources

Submit Your Case

Call 800.291.0963
Live chat is available 24/7, 365 days a year.
Submit Your Case

Working with a Gold Bond product does not automatically establish asbestos exposure or a payable NGC Trust claim. The historical Gold Bond line included both asbestos-containing and non-asbestos products. Product identity, exposure dates, work practices, medical evidence and current Trust procedures must be evaluated individually. The Payment Percentage may change. Compensation is not guaranteed.

⚕️ Legal & Medical Information Disclaimer
This page provides general educational information and is not legal or medical advice. Consult qualified healthcare and legal professionals for individual guidance.